Market Place
Sourcing Support
Egle Therapeutics to Present Preclinical Findings at 2025 AACR Me
22 Apr 2025 //
BUSINESSWIRE
Egle Therapeutics gets €9.3M state funding from France 2030
17 Mar 2025 //
BUSINESSWIRE
Egle Appoints Christophe Quéva As CEO To Strengthen Leadership
13 Jan 2025 //
BUSINESSWIRE
Egle Therapeutics Shares Data for EGL-001 at Immunotherapy Meeting
25 Oct 2024 //
BUSINESSWIRE
Egle Therapeutics To Present EGL-003 Data At IL-2 Therapy Meeting
17 Jul 2024 //
BUSINESSWIRE
EGLE Appoints Motlagh CMO, Celebi Board Member
10 May 2024 //
BUSINESSWIRE
Egle to present data for EGL-001 with presentation at the 2024 AACR Meeting
04 Apr 2024 //
BUSINESSWIRE
Egle Strengthens its Team with the Appointment of Monica Gostissa, as CSO
27 Mar 2024 //
BUSINESSWIRE
Egle Therapeutics Appoints Pierre Legault as Chairman and Board Member
05 May 2022 //
BUSINESSWIRE
Lilly, Bayer, Merck catch classical buzz with $55M for Mozart Tx
27 Oct 2021 //
FIERCEBIOTECH
Egle Therapeutics nabs $46M for pipeline push
23 Oct 2021 //
BUSINESSWIRE
Egle Identifies First Novel Regulatory T-cell Targets inResearch Alliance Takeda
28 Nov 2020 //
BUSINESSWIRE
Egle Therapeutics Identifies First Novel Regulatory T-cell Targets
25 Nov 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.